Oncology Reports 2014-11-01

The endogenous oxindole isatin induces apoptosis of MCF‑7 breast cancer cells through a mitochondrial pathway.

Zhongliang Ma, Lin Hou, Yuhong Jiang, Yanpin Chen, Jinlian Song

Index: Oncol. Rep. 32(5) , 2111-7, (2014)

Full Text: HTML

Abstract

Isatin is an endogenous indole in mammalian tissues and fluids that is expected to have antitumor effects in human breast cancer cells. Human breast cancer cells (MCF-7) were exposed to isatin at various concentrations (0, 50, 100, 200 µmol/l) for 48 h. Apoptotic features were demonstrated by nuclei staining with Hoechst 33258 and flow cytometry. Bcl-2 and Bax mRNA were analyzed via reverse transcription-polymerase chain reaction. Bcl-2, Bax, the inhibitor of caspase-activated DNase (ICAD), and cytochrome c protein were analyzed by western blot analysis. Apoptosis, caspase-9 and -3 activation and mitochondrial depolarization were assayed by flow cytometry. The results showed that isatin induced apoptosis of MCF-7 cells. Furthermore, Bcl-2 expression was decreased and the ratio of Bcl-2 to Bax was significantly decreased by isatin. The mitochondrial transmembrane potential was markedly decreased and the release of cytochrome c into the cytosol was elevated following treatment with isatin. At the same time, caspase-9 and -3 were stimulated, followed by the degradation of ICAD, a caspase-3 substrate.


Related Compounds

Related Articles:

CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression.

2014-08-30

[Oncotarget 5(16) , 6756-69, (2014)]

Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption.

2014-01-01

[PLoS ONE 9(7) , e101824, (2014)]

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.

2013-03-01

[Brain Behav. 3(2) , 75-88, (2013)]

Positive feedback regulation of type I IFN production by the IFN-inducible DNA sensor cGAS.

2015-02-15

[J. Immunol. 194(4) , 1545-54, (2015)]

Enhanced Retinal Ganglion Cell Survival in Glaucoma by Hypoxic Postconditioning After Disease Onset.

2015-04-01

[Neurotherapeutics 12(2) , 502-14, (2015)]

More Articles...